Cost-effectiveness analyses of umeclidinium bromide 62.5 mcg versus glycopyrronium 44 mcg and umeclidinium bromide 62.5 mcg versus tiotropium 18 mcg in patients with chronic obstructive pulmonary disease in the UK Meeting Abstract
| Authors: | Shah, D.; Driessen, M.; Risebrough, N.; Baker, T. M.; Naya, I.; Lloyd, E. J.; Briggs, A.; Ismaila, A. |
| Abstract Title: | Cost-effectiveness analyses of umeclidinium bromide 62.5 mcg versus glycopyrronium 44 mcg and umeclidinium bromide 62.5 mcg versus tiotropium 18 mcg in patients with chronic obstructive pulmonary disease in the UK |
| Meeting Title: | 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) |
| Journal Title: | Value in Health |
| Volume: | 20 |
| Issue: | 5 |
| Meeting Dates: | 2017 May 20-24 |
| Meeting Location: | Boston, MA |
| ISSN: | 1098-3015 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2017-05-01 |
| Start Page: | A202 |
| Language: | English |
| ACCESSION: | WOS:000405448002361 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jval.2017.05.005 |
| Notes: | Meeting Abstract: PRS15 -- Source: Wos |
